• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅觉障碍在轻度路易体痴呆患者中比轻度阿尔茨海默病患者更为明显。

Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.

作者信息

Williams S S, Williams J, Combrinck M, Christie S, Smith A D, McShane R

机构信息

Oxfordshire and Buckinghamshire Mental Health Foundation NHS Trust, Dementia Programme, Level 4, John Radcliffe Hospital, Oxford, UK.

出版信息

J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):667-70. doi: 10.1136/jnnp.2008.155895.

DOI:10.1136/jnnp.2008.155895
PMID:19448090
Abstract

BACKGROUND

Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem, but clinicopathological studies have only assessed olfaction in moderate dementia or an average of 5 years before death. It is not known whether, in patients with mild dementia (MMSE score over 20), olfactory function is more impaired in Alzheimer disease (AD) than dementia with Lewy bodies (DLB).

METHODS

Patients with mild DLB (n = 21), mild AD (n = 27), mild cognitive impairment (MCI) (n = 21) and controls (n = 47) were assessed using a 16-item olfactory identification test and an olfactory threshold test which used sticks impregnated with differing concentrations of butanol.

RESULTS

Patients with mild DLB had impaired olfactory identification ability compared with those with mild AD or MCI, independent of age, cognitive function and sex. The sensitivity of a cutoff score of seven correct responses out of 16 was 0.81 for distinguishing mild DLB from mild AD (AUC 0.682). The specificity, positive predictive value and negative predictive value for the same cut-off score were 0.41, 0.48 and 0.73, respectively. The olfactory threshold was not different in the AD and DLB groups.

CONCLUSIONS

Simple bedside tests of olfactory identification merit further examination for their potential to improve the identification of patients with DLB when used alongside existing criteria. They are insufficiently specific for use in screening.

摘要

背景

嗅觉减退的痴呆患者在死后更有可能出现路易体病理改变,但临床病理研究仅评估了中度痴呆患者或死亡前平均5年的嗅觉情况。目前尚不清楚,在轻度痴呆(简易精神状态检查表评分超过20分)患者中,阿尔茨海默病(AD)患者的嗅觉功能是否比路易体痴呆(DLB)患者受损更严重。

方法

使用一项包含16个条目的嗅觉识别测试和一项嗅觉阈值测试,对轻度DLB患者(n = 21)、轻度AD患者(n = 27)、轻度认知障碍(MCI)患者(n = 21)和对照组(n = 47)进行评估。嗅觉阈值测试使用浸有不同浓度丁醇的试纸。

结果

与轻度AD或MCI患者相比,轻度DLB患者的嗅觉识别能力受损,不受年龄、认知功能和性别的影响。16个条目中答对7个作为临界值时,区分轻度DLB与轻度AD的敏感度为0.81(曲线下面积0.682)。相同临界值的特异度、阳性预测值和阴性预测值分别为0.41、0.48和0.73。AD组和DLB组的嗅觉阈值没有差异。

结论

嗅觉识别的简单床边测试在与现有标准一起使用时,其改善DLB患者识别的潜力值得进一步研究。它们用于筛查时特异度不足。

相似文献

1
Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.嗅觉障碍在轻度路易体痴呆患者中比轻度阿尔茨海默病患者更为明显。
J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):667-70. doi: 10.1136/jnnp.2008.155895.
2
Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.嗅觉功能和神经心理学特征在轻度认知障碍患者中鉴别路易体痴呆与阿尔茨海默病:一项5年随访研究
J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.
3
Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.台湾地区轻度至中度路易体痴呆、阿尔茨海默病患者和正常参与者的蒙特利尔认知评估和简易精神状态检查表现。
Int Psychogeriatr. 2013 Nov;25(11):1839-48. doi: 10.1017/S1041610213001245. Epub 2013 Aug 7.
4
Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.区分路易体轻度痴呆与轻度阿尔茨海默病的神经认知缺陷与帕金森症有关。
J Alzheimers Dis. 2016 Jun 30;53(4):1277-85. doi: 10.3233/JAD-160294.
5
High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies.MMSE五角评分法对路易体前驱性痴呆诊断具有高度特异性。
Parkinsonism Relat Disord. 2015 Mar;21(3):303-5. doi: 10.1016/j.parkreldis.2014.12.007. Epub 2014 Dec 16.
6
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.严重嗅觉减退可将神经病理学确诊的路易体痴呆与阿尔茨海默病痴呆区分开来。
PLoS One. 2020 Apr 22;15(4):e0231720. doi: 10.1371/journal.pone.0231720. eCollection 2020.
7
Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease.路易体轻度认知障碍和阿尔茨海默病患者的嗅觉障碍。
Int Psychogeriatr. 2022 Jun;34(6):585-592. doi: 10.1017/S1041610221001265. Epub 2021 Oct 20.
8
The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease.简易精神状态检查表可能有助于区分路易体痴呆和阿尔茨海默病。
Int J Geriatr Psychiatry. 2002 Jun;17(6):503-9. doi: 10.1002/gps.550.
9
Distinguishing Alzheimer's disease and dementia with Lewy bodies using cognitive and olfactory measures.利用认知和嗅觉测量方法区分阿尔茨海默病和路易体痴呆。
Neuropsychology. 2016 Mar;30(3):304-11. doi: 10.1037/neu0000230. Epub 2015 Aug 17.
10
Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease.路易体痴呆和阿尔茨海默病患者的注意力及波动性注意力
Arch Neurol. 2001 Jun;58(6):977-82. doi: 10.1001/archneur.58.6.977.

引用本文的文献

1
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.路易体痴呆:探索淀粉样β蛋白、tau蛋白和α-突触核蛋白的生物标志物及致病相互作用
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
2
Intrinsic capacity in Lewy body dementia: a review.路易体痴呆的内在能力:综述
J Frailty Aging. 2025 Aug;14(4):100076. doi: 10.1016/j.tjfa.2025.100076. Epub 2025 Aug 5.
3
Sex differences in brain atrophy in dementia with Lewy bodies.路易体痴呆症中脑萎缩的性别差异。
Alzheimers Dement. 2024 Mar;20(3):1815-1826. doi: 10.1002/alz.13571. Epub 2023 Dec 22.
4
Disparity of smell tests in Alzheimer's disease and other neurodegenerative disorders: a systematic review and meta-analysis.阿尔茨海默病及其他神经退行性疾病嗅觉测试的差异:系统评价与荟萃分析
Front Aging Neurosci. 2023 Sep 7;15:1249512. doi: 10.3389/fnagi.2023.1249512. eCollection 2023.
5
Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.路易体痴呆的轻度认知障碍:更新与展望。
J Neural Transm (Vienna). 2023 Dec;130(12):1491-1508. doi: 10.1007/s00702-023-02670-1. Epub 2023 Jul 7.
6
Alteration of Neural Pathways and Its Implications in Alzheimer's Disease.神经通路的改变及其在阿尔茨海默病中的意义
Biomedicines. 2022 Apr 4;10(4):845. doi: 10.3390/biomedicines10040845.
7
International consensus statement on allergy and rhinology: Olfaction.国际过敏与鼻科学学会共识声明:嗅觉。
Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929.
8
Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.小胶质细胞与神经退行性疾病患者嗅球中的 p-Tau 聚集物有关。
Neurol Sci. 2021 Apr;42(4):1473-1482. doi: 10.1007/s10072-020-04686-x. Epub 2020 Aug 20.
9
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias.阿尔茨海默病及相关痴呆症诊断的潜在新方法
Front Neurol. 2020 Jun 5;11:496. doi: 10.3389/fneur.2020.00496. eCollection 2020.
10
Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.严重嗅觉减退可将神经病理学确诊的路易体痴呆与阿尔茨海默病痴呆区分开来。
PLoS One. 2020 Apr 22;15(4):e0231720. doi: 10.1371/journal.pone.0231720. eCollection 2020.